Focus Stocks
GlaxoSmithKline Is in a Very Tight Range
Published on Tuesday, 17 July 2012 08:40 Written by TradersHuddle Wire
New York, July 17th (TradersHuddle.com) - Shares of GlaxoSmithKline plc (NYSE:GSK) closed the trading session at $45.30 with its price action in a very tight range, given that calculated support is set at $44.19 and the calculated resistance is set at $46.28.
GlaxoSmithKline plc (NYSE:GSK) is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. Its over the counter medicines and health related consumer products are marketed under brand names like Panadol, Nicorette, Breathe Right, Tums, Aquafresh, and Sensodyne among others.
GlaxoSmithKline's stock price action indicates that both sellers and buyers are materializing very close to each other. This signals an area where momentum is building, since the stock can resolve by breaking out of the developing tight range.
Traders wanting to establish a position should pay close attention to GlaxoSmithKline's price action, as any movement outside its predefined range of $44.19 and $46.28 could grasp the attention of momentum buyers that look for a big movement in the price of the stock. Traders need to be aware that tight range resolution works both ways, hence, a move below support could spark above the average selling. A tiered approach could be the best way to start a position; enter into it while the stock is in the tight range, and then add to this position as it breaks and closes above resistance.
Related Articles
- GlaxoSmithKline Is Near a Key Resistance Area
- BREO™ ELLIPTA™ gains US approval for the treatment of COPD
- Trading Idea: - Is GlaxoSmithKline close to Resistance?
- GlaxoSmithKline Is Moving Above Resistance
- GlaxoSmithKline Is Near a Key Resistance Area
- GlaxoSmithKline Is Moving Above Resistance
- GlaxoSmithKline CFO Interviewed on Q1 2013 Financial Results
- GlaxoSmithKline Is Near a Key Resistance Area
- Above Resistance: GlaxoSmithKline
- FDA Advisory Committee recommends approval of BREO™ ELLIPTA™ for the treatment of COPD
Related Partner Headlines
- GlaxoSmithKline Stock To Go Ex-dividend Tomorrow (GSK) - TheStreet.com
- GlaxoSmithKline PLC (GSK): Today's Featured Drugs Laggard - TheStreet.com
- Buzz on Sarepta's Eteplirsen From London Duchenne Meeting - TheStreet.com
- GlaxoSmithKline PLC (GSK): Today's Featured Health Care Winner - TheStreet.com
- GlaxoSmithKline PLC (GSK): Today's Featured Health Care Winner - TheStreet.com
- United Therapeutics Could Lose The Battle For PAH Therapies - TheStreet.com
- A Prescription for Election Fever - TheStreet.com
- GlaxoSmithKline PLC (GSK): Today's Featured Drugs Laggard - TheStreet.com
- How to Hedge Profits in Sarepta Therapeutics - TheStreet.com
- Lazard Analyst Note on Sarepta Therapeutics Is Generating Buzz - TheStreet.com
TradersHuddle Search
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Dow Today: Verizon Communications (VZ) Higher - TheStreet.com -
Separating the Bargains From the Busts - TheStreet.com -
Cramer Quick Take: The 60-Inch TV Will Be Key This Holiday - TheStreet.com -
Cramer Quick Take: Cisco Wins If Fiscal Cliff Is Resolved - TheStreet.com -
Gap Up and Sit - TheStreet.com -
Apple, Intel, MicroStrategy: Tech Winners & Losers - TheStreet.com -
Windows 8 PC Sales Disappointing: Report - TheStreet.com -
Cramer Quick Take: Buy Home Depot and Lowe's - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:15,354.40 Trade time:4:40PM EDT Value change:▲121.18 (0.80%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,667.47 Trade time:4:39PM EDT Value change:▲17.00 (1.03%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:3,498.97 Trade time:5:15PM EDT Value change:▲33.73 (0.97%)In The Wires
-
Detroit Pistons NBA Apparel at SportsFanPlayground.com -
Three Steps to Success for Local Businesses with Local Marketing Online Based on May Studies -
DJ Ty Goodwin Confirmed Act At Drawing On The Moon -
Results Matter Radio Spotlights Sustainability in Georgia and the Southeast on Business RadioX -
Illuminations Brings World Renowned Therapist to the Middle East -
ForexMinute Now Offers Visual Charts Review, a LeadingTrading Software Provider -
Bluffton South Carolina - Fastest Growing Town in the Low Country -
Analyst Jeff Kagan Congratulates Samsung on 10M Galaxy S4 Sales








